Omer Ozkan, M. D. , Munire Erman Akar, M. D. , Ozlenen Ozkan, M. D

Slides:



Advertisements
Similar presentations
Effect of detorsion alone and in combination with enoxaparin therapy on ovarian reserve and serum antimüllerian hormone levels in a rat ovarian torsion.
Advertisements

The effectiveness of gonadotropin-releasing hormone antagonist in poor ovarian responders undergoing in vitro fertilization: a systematic review and meta-analysis 
Bulent Haydardedeoglu, M. D. , Erhan Simsek, M. D
Development of Asherman syndrome after conservative surgical management of intractable postpartum hemorrhage  Ciaran A. Goojha, M.D., Allison Case, M.D.,
Yuqian Cui, M. D. , Ph. D. , Yuhua Shi, M. D. , Ph. D. , Linlin Cui, M
Relationships between the luteinizing hormone surge and other characteristics of the menstrual cycle in normally ovulating women  Ana Direito, M.D., Sébastien.
Complete septate uterus with longitudinal vaginal septum
A normal uterus communicating with a double cervix and the vagina: a müllerian anomaly without any present classification  Kyoko Shirota, M.D., Miyoko.
Modified human uterus transplantation using ovarian veins for venous drainage: the first report of surgically successful robotic-assisted uterus procurement.
Bicornuate rudimentary uterine horns with functioning endometrium and complete cervical-vaginal agenesis coexisting with ovarian endometriosis: a case.
Live birth after ovarian tissue autograft in a patient with sickle cell disease treated by allogeneic bone marrow transplantation  Christophe Roux, M.D.,
The normal variabilities of the menstrual cycle
Michael M. Alper, M.D.  Fertility and Sterility 
Four spontaneous pregnancies and three live births following subcutaneous transplantation of frozen banked ovarian tissue: What is the explanation?  Kutluk.
Administration of a gonadotropin-releasing hormone antagonist during the 3 days before the initiation of the in vitro fertilization/intracytoplasmic sperm.
The luteal phase of recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in vitro fertilization cycles during supplementation.
Conservative management of cervical ectopic pregnancy
Growth rates of ovarian follicles during natural menstrual cycles, oral contraception cycles, and ovarian stimulation cycles  Angela R. Baerwald, Ph.D.,
Cem Atabekoglu, M. D. , Murat Sonmezer, M. D. , Sinan Özkavukcu, M. D
Comparison of fallopian tube sperm perfusion and intrauterine tuboperitoneal insemination: a prospective randomized study  Leonidas Mamas, M.D., Ph.D. 
Reconstructive surgical management of cryptomenorrhea because of complex uterovaginal malformations with duplicate uterus and complete vaginal agenesis 
Hakan Cakmak, M. D. , Audra Katz, R. N. , Marcelle I. Cedars, M. D
A comparison of blood spot vs
A Markov model of the cost-effectiveness of human-derived follicle-stimulating hormone (FSH) versus recombinant FSH using comparative clinical trial data 
Andrea B. Palmer, M.D., John C. Siegle, M.D.  Fertility and Sterility 
Prevalence of premature urinary luteinizing hormone surges in women with regular menstrual cycles and its effect on implantation of frozen-thawed embryos 
Leiomyoma on the septum of a septate uterus with double cervix and vaginal septum: a challenge to manage  Eray Caliskan, M.D., Yiğit Cakiroglu, M.D.,
Uterine viability in the baboon after ligation of uterine vasculature: a pilot study to assess alternative perfusion and venous return for uterine transplantation 
Impact of luteal phase support on pregnancy rates in intrauterine insemination cycles: a prospective randomized study  Ahmet Erdem, M.D., Mehmet Erdem,
Bulent Haydardedeoglu, M. D. , Erhan Simsek, M. D
Extremely elevated serum CA-125 level as a result of unruptured unilateral endometrioma: the highest value reported  Korhan Kahraman, M.D., Irem Ozguven,
Delayed diagnosis of partially obstructed longitudinal vaginal septa
Chronic isolated fallopian tube torsion
René Ecochard, M. D. Ph. D. , Agnes Guillerm, M. D. , René Leiva, M. D
Serum luteinizing hormone levels are markedly increased and significantly correlated with Δ4-androstenedione levels in lean women with polycystic ovary.
The effectiveness of gonadotropin-releasing hormone antagonist in poor ovarian responders undergoing in vitro fertilization: a systematic review and meta-analysis 
Duphaston and human menopausal gonadotropin protocol in normally ovulatory women undergoing controlled ovarian hyperstimulation during in vitro fertilization/intracytoplasmic.
Tomer Singer, M. D. , David H. Barad, M. D. , M. S
Robotic-assisted laparoscopic ovarian tissue transplantation
Comparison of markers of ovarian reserve between patients with complete müllerian agenesis and age-matched fertile and infertile controls  Murat Ozekinci,
Obesity reduces uterine receptivity: clinical experience from 9,587 first cycles of ovum donation with normal weight donors  José Bellver, M.D., Antonio.
Synchronization of ovarian stimulation with follicle wave emergence in patients undergoing in vitro fertilization with a prior suboptimal response: a.
Francesco Plotti, M. D. , Alessandra Di Giovanni, M. D
Difficulties improving ovarian functional recovery by microvascular transplantation and whole ovary vitrification  Blandine Courbiere, M.D., Ludovic Caquant,
Pascale Jadoul, M. D. , Jacques Donnez, M. D. , Ph. D
Development of Asherman syndrome after conservative surgical management of intractable postpartum hemorrhage  Ciaran A. Goojha, M.D., Allison Case, M.D.,
Impact of laparoscopic ovarian drilling on anti-Müllerian hormone levels and ovarian stromal blood flow using three-dimensional power Doppler in women.
María A. Higón, M. D. , Santiago Domingo, M. D. , Celia Bauset, M. D
Paolo Moghetti, M.D.  Fertility and Sterility 
Follicular phase serum levels of luteinizing hormone do not influence delivery rates in in vitro fertilization cycles down-regulated with a gonadotropin-releasing.
Sedigheh Borna, M.D., Azita Nasery, M.D.  Fertility and Sterility 
Impact of subclinical hypothyroidism in women with recurrent early pregnancy loss  Lia A. Bernardi, M.D., Ronald N. Cohen, M.D., Mary D. Stephenson, M.D.,
Use of Utrogestan during controlled ovarian hyperstimulation in normally ovulating women undergoing in vitro fertilization or intracytoplasmic sperm injection.
Ovarian cystic teratoma with a pathognomonic appearance of multiple floating balls: a case report and investigation of common characteristics of the cases.
Current evaluation of amenorrhea
Genetic evaluation procedures at sperm banks in the United States
A woman with premature ovarian failure induced by Tripterygium wilfordii Hook.f. gives birth to a healthy child  Xin Chen, M.D., M.Sc., Shi-ling Chen,
David H. Barad, M.D., M.S., Norbert Gleicher, M.D. 
True ovarian volume is underestimated by two-dimensional transvaginal ultrasound measurement  Mikkel Rosendahl, M.D., Erik Ernst, Ph.D., Per Emil Rasmussen,
In vitro sildenafil citrate use as a sperm motility stimulant
Obstructed uteri with a cervix and vagina
Uterine didelphys with duplicated upper vagina and bilateral lower vaginal agenesis: a novel Müllerian anomaly with options for surgical management  Whitfield.
Microdose gonadotropin-releasing hormone agonist in the absence of exogenous gonadotropins is not sufficient to induce multiple follicle development 
Noam Smorgick, M. D. , Yaakov Melcer, M. D. , Tal Sarig-Meth, B. S
Diabetes mellitus and insulin resistance in mothers, fathers, sisters, and brothers of women with polycystic ovary syndrome: a systematic review and meta-analysis 
Anat Hershko-Klement, M.D., Ronnie Tepper, M.D. 
Dalmo Borges Ramos, M. D. , Newton Eduardo Busso, Ph. D
Comparisons of inhibin B versus antimüllerian hormone in poor ovarian responders undergoing in vitro fertilization  Rongrong Tan, M.M.Sc., Danhua Pu,
Oocyte retrieval timing based on spontaneous luteinizing hormone surge during natural cycle in vitro fertilization treatment  Daniel Bodri, M.D., M.Sc.,
Recurrence of ovarian torsion in a multiple pregnancy: conservative management via transabdominal ultrasound–guided ovarian cyst aspiration  Kathleen.
Presentation transcript:

Preliminary results of the first human uterus transplantation from a multiorgan donor  Omer Ozkan, M.D., Munire Erman Akar, M.D., Ozlenen Ozkan, M.D., Okan Erdogan, M.D., Necmiye Hadimioglu, M.D., Murat Yilmaz, M.D., Filiz Gunseren, M.D., Mehmet Cincik, M.D., Elif Pestereli, M.D., Huseyin Kocak, M.D., Derya Mutlu, M.D., Ayhan Dinckan, M.D., Omer Gecici, M.D., Gamze Bektas, M.D., Gultekin Suleymanlar, M.D.  Fertility and Sterility  Volume 99, Issue 2, Pages 470-476.e5 (February 2013) DOI: 10.1016/j.fertnstert.2012.09.035 Copyright © 2013 American Society for Reproductive Medicine Terms and Conditions

Figure 1 The donor uterus with its vasculature and peritoneum following recovery and perfusion. BP, bladder peritoneum; LFT, left fallopian tube; LHAV, left hypogastric artery and vein; LOAV, left ovarian artery and vein; RFT, right fallopian tube; ROAV, right ovarian artery and vein; RHAV, right hypogastric artery and vein; U, uterus; V, vagina. Fertility and Sterility 2013 99, 470-476.e5DOI: (10.1016/j.fertnstert.2012.09.035) Copyright © 2013 American Society for Reproductive Medicine Terms and Conditions

Figure 2 Schematic representation of the surgical procedure. EIA: recipient external iliac artery; EIV: recipient external iliac vein; HA: donor hypogastric artery; HV: donor hypogastric vein; O: recipient ovary; U: donor uterus; V/V: recipient and donor vaginas. Note bilateral salpingeal tubes were ligated. Fertility and Sterility 2013 99, 470-476.e5DOI: (10.1016/j.fertnstert.2012.09.035) Copyright © 2013 American Society for Reproductive Medicine Terms and Conditions

Figure 3 Three-dimensional ultrasonographic appearance of the transplanted uterus and endometrium at 5 months after transplantation. Fertility and Sterility 2013 99, 470-476.e5DOI: (10.1016/j.fertnstert.2012.09.035) Copyright © 2013 American Society for Reproductive Medicine Terms and Conditions

Figure 4 Uterine artery blood flow at 7 months after transplantation. Fertility and Sterility 2013 99, 470-476.e5DOI: (10.1016/j.fertnstert.2012.09.035) Copyright © 2013 American Society for Reproductive Medicine Terms and Conditions

Supplemental Figure 1 View of the transplanted cervix at 11 months after transplantation. Fertility and Sterility 2013 99, 470-476.e5DOI: (10.1016/j.fertnstert.2012.09.035) Copyright © 2013 American Society for Reproductive Medicine Terms and Conditions

Supplemental Figure 2 Pathologic aspects of the vaginal mucosa specimen showing CD4 lymphocytes at 6 months after transplantation (arrow shows CD4 lymphocytes). Fertility and Sterility 2013 99, 470-476.e5DOI: (10.1016/j.fertnstert.2012.09.035) Copyright © 2013 American Society for Reproductive Medicine Terms and Conditions

Supplemental Figure 3 Pathologic aspects of the endometrium showing vacuolization of the glandular epithelium and edematous stroma at 6 months after transplantation. Fertility and Sterility 2013 99, 470-476.e5DOI: (10.1016/j.fertnstert.2012.09.035) Copyright © 2013 American Society for Reproductive Medicine Terms and Conditions

Supplemental Figure 4 Diagram of the luteinizing hormone (LH) and follicle-stimulating hormone (FSH) changes during menstrual cycles after transplantation. (*Denotes first day of menstrual cycle.) Fertility and Sterility 2013 99, 470-476.e5DOI: (10.1016/j.fertnstert.2012.09.035) Copyright © 2013 American Society for Reproductive Medicine Terms and Conditions

Supplemental Figure 5 Diagram of the estradiol (E2) changes during menstrual cycles posttransplantation. (*Denotes first day of menstrual cycle.) Fertility and Sterility 2013 99, 470-476.e5DOI: (10.1016/j.fertnstert.2012.09.035) Copyright © 2013 American Society for Reproductive Medicine Terms and Conditions